How much funding has Alkahest raised?

Alkahest has disclosed $3.5M raised across 1 round.

Where is Alkahest headquartered?

Alkahest is headquartered in Redwood City, US.

Alkahest

Redwood City, US · Founded 2014

Alkahest, a subsidiary of Grifols, is a drug discovery company that analyzes the plasma proteome using AI and multiomics to identify biomarkers and develop therapies for age-related and neurodegenerative diseases. Its pipeline targets conditions including wet AMD, Parkinson's disease, and Alzheimer's disease.

AI & Machine Learning Biotech Longevity

Founders & leadership

Anton Wyss-CorayNamed on SEC filing

Tamara KentNamed on SEC filing

Karoly NikolichNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$3.5M disclosed across 1 round · 2014

▶$3.5MraisedAug 2014 · 3 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Anton Wyss-CorayDirector
Tamara KentExecutive Officer
Karoly NikolichExecutive Officer, Director

Offering amount: $3.5M
Amount sold: $3.5M
Minimum investment: $300K
Proceeds to insiders: $324K
First sale: Jul 2014
Incorporated: Corporation, Delaware, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Alkahest do?: Alkahest, a subsidiary of Grifols, is a drug discovery company that analyzes the plasma proteome using AI and multiomics to identify biomarkers and develop therapies for age-related and neurodegenerative diseases. Its pipeline targets conditions including wet AMD, Parkinson's disease, and Alzheimer's disease.
How much funding has Alkahest raised?: Alkahest has disclosed $3.5M raised across 1 round.
Where is Alkahest headquartered?: Alkahest is headquartered in Redwood City, US.